-
Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP)
Источник: Buzz FX / 06 ноя 2024 08:48:16 America/New_York
Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP) Written by MarketBeat November 6, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "buy" rating res
Read more...